Form 4: Intercontinental Exchange Executive Sells Shares Under 10b5-1 Trading Plan

Christopher Scott Edmonds, President of Fixed Income & Data at Intercontinental Exchange, sold 551 shares of common stock at $134.40 per share on June 3, 2024, under a pre-arranged trading plan.

Summary

• On June 3, 2024, Christopher Scott Edmonds, President of Fixed Income & Data at Intercontinental Exchange, sold 551 shares of common stock at a price of $134.40 per share.
• The transaction was executed under a Rule 10b5-1 trading plan that was approved and became effective on March 4, 2024.
• Following the transaction, Edmonds beneficially owns 15,538 shares of Intercontinental Exchange common stock.
• This total includes 4,231 shares of common stock, 1,018 unvested restricted stock units (RSUs), and 10,289 unvested performance-based restricted stock units (PSUs) for which the performance period has been satisfied.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a routine stock sale. There is no inherent positive or negative sentiment associated with the information provided.

Future Outlook

The satisfaction of performance-based restricted stock units and the corresponding number of shares to be issued will be determined and reported at various future vesting dates.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by an executive officer, which is common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• Companies like Nasdaq, CME Group, and London Stock Exchange Group also have executives who regularly file Form 4s when they trade company stock.
• The use of 10b5-1 trading plans is a common strategy among executives to avoid accusations of insider trading, aligning with industry best practices.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but it is unlikely to be significant given the relatively small number of shares involved and the pre-planned nature of the transaction.
• The transaction does not appear to have any direct impact on employees, customers, suppliers, or creditors.

Next Steps

• The satisfaction of the 2024 PSUs tied to EBITDA will be determined in February 2025 and reported at the time of vesting.
• The satisfaction of the 2022, 2023 and 2024 total shareholder return performance based restricted stock units will be determined in February 2025, February 2026 and February 2027, respectively, and will be reported at the time of vesting.
• The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards will be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

Key Dates